Atorvastatin attenuates cognitive deficits through Akt1/caspase-3 signaling pathway in ischemic stroke
Authors:
- 1 December 2015
- journal article
- Published by Elsevier in Brain Research
- Vol. 1629, 231-239
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Increased susceptibility to pentetrazol-induced seizures in developing rats after cortical photothrombotic ischemic stroke at P7Brain Research, 2013
- Evaluation of neurobehavioral deficits following different severities of cerebral ischemia in rats: A comparison between the modified hole board test and the Morris water maze testBehavioural Brain Research, 2012
- Heat shock protein 72 inhibits c-Jun N-terminal kinase 3 signaling pathway via Akt1 during cerebral ischemiaJournal of the Neurological Sciences, 2012
- Synergistic Memory Impairment Through the Interaction of Chronic Cerebral Hypoperfusion and Amlyloid Toxicity in a Rat ModelStroke, 2011
- Calcium/calmodulin-dependent kinase II facilitated GluR6 subunit serine phosphorylation through GluR6-PSD95-CaMKII signaling module assembly in cerebral ischemia injuryBrain Research, 2010
- Neuroprotective Effect of Palmul-Chongmyeong-Tang on Ischemia-Induced Learning and Memory Deficits in the RatBiological and Pharmaceutical Bulletin, 2007
- Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic strokeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- High-Dose Atorvastatin after Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2006
- Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injuryJournal of Neurochemistry, 2006
- Neuroprotective effects of preconditioning ischaemia on ischaemic brain injury through inhibition of mixed‐lineage kinase 3 via NMDA receptor‐mediated Akt1 activationJournal of Neurochemistry, 2005